Former CytoDyn CEO Nader Pourhassan, Ph.D., has received a 30-month prison sentence, or two and a half years, after being convicted on charges related to defrauding biotech investors. The ex-CytoDyn ...
VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal ...
VANCOUVER, Washington, May 13, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
CytoDyn’s legal fight with Amarex Clinical Research appears to be coming to an end. The biotech announced July 9 that it has reached a settlement in which the CRO, a former partner of the company, ...
CEO Jacob Lalezari released the following letter: “As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your support, patience, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results